Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Military-Compliant Labeling and Barcoding

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract requires the application of MIL-STD-129 compliant labels to pharmaceutical packaging and shipping units, ensuring adherence to Department of Defense standards for military supply chain logistics. The labeling must include U/I items, QUP identifiers, and traceable barcodes to maintain full inventory visibility and accountability throughout distribution. All work must be performed at the specified place of performance in Williamsburg, Virginia, with a strict deadline for submission on July 27, 2026. The contract is classified as a subcontract under NAICS code 323111, which pertains to photographic and photocopying services but is here leveraged in the context of medical supply labeling operations for the Medical Supply Chain Pharm FSA under the Department of Defense. Compliance with military labeling specifications is mandatory, and failure to meet these requirements may result in rejection of delivered goods.

General Info

Apply MIL-STD-129 labels with U/I, QUP, barcodes at Williamsburg, VA by July 27, 2026 for DoD pharmaceutical supply chain.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

323111 - Commercial Printing (except Screen and Books)View NAICS

Place of Performance

WILLIAMSBURG, VA, 23185-5830, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Apply MIL-STD-129 compliant labels with U/I, QUP, and traceable barcodes to pharmaceutical packaging and shipping units.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 323113
New
DIBBS
Hazardous & Medical Materials Packaging and LabelingThe contract mandates the repackaging and labeling of medical and hazardous materials to ensure full compliance with OSHA, MIL-STD-129, and MMS NO. 1 standards, covering all aspects of safe handling, transportation, and identification. This work is critical for maintaining regulatory adherence and operational readiness within military and federal medical supply chains, requiring precise labeling, durable packaging, and documented quality control procedures to meet stringent defense and safety requirements. The contract is structured as a subcontract under the NAICS code 323113, indicating specialized printing and related support activities tailored to government specifications. Performance is required at Sea Girt, New Jersey, with a response deadline of July 27, 2026, and the solicitation was posted on July 20, 2026. The awarding agency is the Medical Supply Chain Pharm FSA under the Department of Defense, emphasizing the defense-critical nature of the materials and services involved. All work must align with established federal guidelines for hazardous material identification and logistics integrity, and the successful vendor must demonstrate capability in handling sensitive medical supplies through certified processes and proven compliance experience. The contract details are accessible via the DIBBS platform for qualified subcontractors to review and submit proposals.
Commercial Screen Printing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
Medical Pharmaceutical Supply – Sodium Chloride InjectionThe contract encompasses the supply of sterile, nonpyrogenic Sodium Chloride Injection intended for fluid and electrolyte replenishment, with all products required to meet United States Pharmacopeia standards and medical labeling requirements. The packaging must comply with stringent regulatory specifications to ensure safety, purity, and suitability for clinical use. This procurement is issued as a subcontract under the NAICS code 325412, targeting manufacturers or distributors capable of delivering reliable, high-quality pharmaceuticals in accordance with federal medical supply protocols. The place of performance is designated as Sea Girt, New Jersey, with a zip code of 08750-0000, indicating the operational location for fulfillment and delivery. The solicitation was posted on July 20, 2026, with a firm response deadline of July 27, 2026, placing this as a time-sensitive opportunity for qualified vendors. The contracting agency is the Department of Defense through its Medical Supply Chain Pharm FSA, signaling the product is destined for use within military or government healthcare systems. All bidders must ensure their submissions align with the requirements specified in the DIBBS portal, accessible via the provided link, and be prepared to demonstrate capacity for consistent production, quality control, and timely delivery of large-scale pharmaceutical quantities to meet critical operational needs.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, with 7.5% active ingredient, is designated for external use only and must be delivered with at least 31 months of shelf life remaining from a total 36-month expiration period. The product is packaged in 1-gallon bottles, identified by unit of issue BT, and must be stored at 25°C (77°F) with permitted excursions between 15°C and 30°C (59°F to 86°F). It is regulated by the FDA and classified as a hazardous material under Federal Standard No. 313-E, requiring suppliers to provide Safety Data Sheets and Hazard Communication Standard-compliant labels in accordance with 29 C.F.R. 1910.1200. Employee training on these requirements is mandatory. Packaging must meet DLA’s Master List of Technical and Quality Requirements, including RP001 for packaging and RQ011 for removal of government identification from non-accepted supplies, superseding MIL-STD-129 in favor of Medical Marking Standard No. 1. All units must be sealed, commercially packaged, and palletized per DLA guidelines to ensure safe transport under the lowest possible freight rates. The contract specifies two line items totaling 7 gallons (2 BT + 5 BT), both with identical product specifications, delivery requirements, and compliance obligations. Delivery is FOB destination within 20 days, with zero quantity variance permitted and inspection and acceptance occurring at the destination. Two delivery points are listed: one in San Diego, California, for USNS JOHN GLENN and another in Norfolk, Virginia, for USNS CODY. Shipments must use the fastest traceable means, explicitly prohibiting parcel post. Each shipment must be labeled with RDD 777, project codes, and government-specific identifiers, and the original required delivery date is July 22, 2026. The contract is issued under solicitation SPE2DP-26-T-4200, referencing NSN 6505-00-994-7224 and approved manufacturer part numbers from Cardinal Health and Purdue Pharma. All technical, quality, and packaging requirements take precedence over any commercial standards not explicitly endorsed by the DLA.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
SODIUM HYPOCHLORITE SOSodium hypochlorite solution, modified at 0.125 percent strength, is being procured in 480 milliliter (16 oz) bottles under the part number NDC00436-0672-16 by Century Pharmaceuticals Inc for use as a medical disinfectant. The item is classified as a FDA-regulated drug with a strict 12-month non-extendable shelf life and must be stored at controlled room temperature. Packaging and marking must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all shipments must comply with DLA packaging requirements and hazardous materials handling guidelines. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport via common carrier at the lowest rate. The delivery is FOB destination with zero variance allowed and must be completed within 20 days of contract award, with inspection and acceptance occurring at the delivery point. The destination is the USNS MERCY medical treatment facility, and traceable freight shipping is required—parcel post is prohibited. The NSN is 6505015887606, and the solicitation number is SPE2DP-26-T-4202 with a response deadline of July 27, 2026 and a required delivery date of July 20, 2026. All bidders must provide source and part number details and comply with DLA’s master list of technical and quality requirements, including those referenced under RS011, RA001, RP001, and RQ011. The contract also includes covered defense information provisions and requires adherence to specific labeling and shipment standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325411
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.
Medicinal and Botanical Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541380
New
DIBBS
Regulatory Compliance and Quality Assurance for Pharmaceutical DeliveriesThis contract requires adherence to current good manufacturing practices cGMP FDA regulations and military quality standards for all pharmaceutical deliveries to ensure product integrity and compliance throughout the supply chain. Key responsibilities include conducting preshipment audits to verify product quality and documentation, maintaining full traceability from manufacturer to final destination, and providing on site inspection support at the point of delivery to confirm compliance with all regulatory and operational requirements. All activities must align with the stringent expectations of the Department of Defense’s Medical Supply Chain Pharmaceutical FSA and ensure that products intended for military use meet the highest benchmarks for safety efficacy and accountability. The performance location is designated as FPO with a zip code of 96674 indicating a military postal address potentially serving overseas or remote military facilities. The solicitation was posted on July 19 2026 with a response deadline of July 27 2026 and is classified as a subcontract under NAICS code 541380 which corresponds to other scientific and technical consulting services. The contract emphasizes rigorous quality control measures and is aimed at supporting critical medical supply operations within the Department of Defense’s pharmaceutical distribution network.
Testing Laboratories and Services

POSTED

1 day ago

DEADLINE

in 7 days
View Details